Published in
Elsevier, The Lancet, 9890(382), p. 409-416, 2013
DOI: 10.1016/s0140-6736(13)60995-2
Links
Tools
Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled study
Journal article published in 2013 by
W. David Strain 
,
Valentina Lukashevich,
Wolfgang Kothny,
Marie-José Hoellinger,
Päivi Maria Paldánius
,
Valentina Lukashevich,
Wolfgang Kothny,
Marie-José Hoellinger,
Päivi Maria Paldánius
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 